Pharmacological Action and Research Progress of Taraxasterol.

anti-inflammatory anti-oxidation anti-tumor dandelion pharmacological taraxasterol

Journal

Current pharmaceutical biotechnology
ISSN: 1873-4316
Titre abrégé: Curr Pharm Biotechnol
Pays: Netherlands
ID NLM: 100960530

Informations de publication

Date de publication:
04 Jan 2024
Historique:
received: 10 08 2023
revised: 30 10 2023
accepted: 10 11 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 5 1 2024
Statut: aheadofprint

Résumé

Primarily sourced from Asteraceae family herbs such as the Dandelion, Taraxasterol is a pentacyclic triterpenoid lauded for its extensive biological functionalities. Its therapeutic potency is demonstrated in various disease models, encompassing enteritis, arthritis, acute hepatic injury, and pneumonia. Scientific literature underscores its anti-inflammatory, antioxidant, and antineoplastic attributes. The primary aim of this study is to thoroughly explore the diseasemodulating mechanisms and effects of taraxasterol. We endeavor to provide an exhaustive review of the experimental subjects, intervention components, distinct action modalities, contributing factors, and protein pathway expressions associated with taraxasterol, systematically represented via diagrams and tables. Such a schematic representation encourages a continued academic dialogue concerning taraxasterol's pharmacological characteristics. This review is envisioned as a practical guide for the selection of experimental subjects and methodologies in prospective research. It is intended to further illuminate taraxasterol's pharmacodynamics, thereby offering theoretical and empirical justification for its clinical application.

Identifiants

pubmed: 38178677
pii: CPB-EPUB-136986
doi: 10.2174/0113892010276692231220103636
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Yu Zhang (Y)

School of dental sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.
Qilu Medical University, Zibo, China.

Ramizu Bin Shaari (RB)

Universiti Sains Malaysia Oral and Maxillofacial Surgery Unit Kota Bharu Malaysia.

Mohamad Arif Bin Awang Nawi (MAB)

School of dental sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.

Akram Bin Hassan (AB)

School of dental sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.

Caiyun Cui (C)

Department of Stomatology, Affiliated Hospital of Binzhou Medical University, Binzhou, China.

Classifications MeSH